Đang chuẩn bị liên kết để tải về tài liệu:
A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United States

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

The National Comprehensive Cancer Network recommends that patients with hormone receptorpositive early breast cancer be considered for adjuvant endocrine therapy (ET) after primary treatment like surgical excision. |